A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000811 |
Recruitment Status
:
Completed
First Posted
: August 31, 2001
Last Update Posted
: April 4, 2012
|
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators:
Pfizer
Glaxo Wellcome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Primary Completion Date : | No date given |
Actual Study Completion Date : | November 2001 |
Publications:
Ngo LY, Yogev R, Dankner WM, Hughes WT, Xu J, Unadkat J. Pharmacokinetics of azithromycin (AZ) when administered alone and with atovaquone (AT). Conf Retroviruses Opportunistic Infect. 1998 Feb 1-5;5th:174 (abstract no 506)